Insights
News
10 YEARS NATIONAL COUNCIL ON PRICES AND REIMBURSEMENT OF MEDICINAL PRODUCTS
Sqilline is proud to celebrate this event as the trusted technology solution provider utilising REAL-WORLD EVIDENCE to IMPROVE ONCOLOGY CARE on a NATIONAL LEVEL ...
News
Artificial intelligence detects first patients with rare neurological disease. Danny Platform enables screening and early diagnosis for high-risk patients
Interview with Prof. Milanov and Prof. Bogdanova, published in Kapital Health, December 2022 Prof. Milanov Prof. Dr. Ivan Milanov, Ph.D., is the Executive Director of...
Case Studies
First patients diagnosed with rare disease with assist of AI algorithm are a fact
Sqilline and a leading pharmaceutical company have partnered to apply an AI algorithm and track high-risk patients for the rare disease of Transthyretin amyloid polyneuropathy (TTR)....